ASLRF yields 117647.06% · JNJ yields 2.13%● Live data
📍 ASLRF pulled ahead of the other in Year 1
Combined, ASLRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASLRF + JNJ for your $10,000?
Alien Metals Ltd, together with its subsidiaries, engages in the acquisition and development of mineral resource assets. The company explores for copper, zinc, lead, silver, gold, iron ore, and precious metal deposits. The company holds a 100% interest in Vivash Gorge Iron Ore Project located in the Pilbara region of Western Australia. It also holds interest in the Donovan 2 project, the Los Campos project, and the San Celso project located in Mexico; the Elizabeth Hill project, the Munni Munni North project, the Munni Munni PGE project, and the Brockman and Hancock iron project situated in Western Australia; and the Citronen project located in Greenland. The company was formerly known as Arian Silver Corporation and changed its name to Alien Metals Limited in October 2018. Alien Metals Ltd was founded in 2006 and is headquartered in London, the United Kingdom.
Full ASLRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.